Issued Patents All Time
Showing 1–25 of 41 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12129294 | Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies | Gregg Timony, Sheila Gujrathi, Allan Olson | 2024-10-29 |
| 12122826 | Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies | Gregg Timony, Sheila Gujrathi, Allan Olson | 2024-10-22 |
| 11390669 | Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies | Gregg Timony, Sheila Gujrathi, Allan Olson | 2022-07-19 |
| 11278526 | Compounds and methods for treating lupus | Fiona Lorraine Scott, Kristen R. Taylor Meadows | 2022-03-22 |
| 10590183 | BSL2v2c2-Ig polypeptides | Glen Eugene Mikesell, Han Chang | 2020-03-17 |
| 10400023 | B7-related nucleic acids and polypeptides useful for immunomodulation | Glen Eugene Mikesell, Han Chang | 2019-09-03 |
| 10370428 | Methods of treatment using CTLA4 mutant molecules | Joseph Naemura, Peter S. Linsley, Jurgen Bajorath | 2019-08-06 |
| 10308702 | BSL2v2c2-Ig polypeptides | Glen Eugene Mikesell, Han Chang | 2019-06-04 |
| 10239846 | Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis | Esther Martinborough, Marcus F. Boehm, Adam Yeager, Junko Tamiya, Liming Huang +6 more | 2019-03-26 |
| 10052360 | Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule | Robert E. Cohen, Suzette Belder-Carr, David Hagerty, Jean-Claude Becker | 2018-08-21 |
| 9758565 | Methods of treatment using CTLA4 mutant molecules | Joseph Naemura, Peter S. Linsley, Jurgen Bajorath | 2017-09-12 |
| 9409970 | Polynucleotides encoding BSL2v2c2 | Glen Eugene Mikesell, Han Chang, Joshua Finger, Guchen Yang, Henry Shen | 2016-08-09 |
| 9399052 | Polynucleotides encoding BSL2v2c2-Ig | Glen Eugene Mikesell, Henry Shen, Han Chang, Joshua Finger, Guchen Yang | 2016-07-26 |
| 9388147 | Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis | Esther Martinborough, Marcus F. Boehm, Adam Yeager, Junko Tamiya, Liming Huang +6 more | 2016-07-12 |
| 9296808 | Methods for treating scleroderma by administering a soluble CTLA4 molecule | Robert E. Cohen, Suzette Belder-Carr, David Hagerty, Jean-Claude Becker | 2016-03-29 |
| 8785398 | Methods of treatment using CTLA4 mutant molecules | Joseph Naemura, Peter S. Linsley, Jurgen Bajorath | 2014-07-22 |
| 8722632 | Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule | Robert E. Cohen, Suzette Belder-Carr, David Hagerty, Jean-Claude Becker | 2014-05-13 |
| 8703718 | Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule | Robert E. Cohen, Suzette Belder-Carr, David Hagerty, Jean-Claude Becker | 2014-04-22 |
| 8674076 | BSL2vcvc-lg polypeptides | Glen Eugene Mikesell, Han Chang | 2014-03-18 |
| 8664360 | BSL3 polypeptides | Glen Eugene Mikesell, Han Chang | 2014-03-04 |
| 8497247 | Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule | Robert E. Cohen, Suzette Carr, David Hagerty, Jean-Claude Becker | 2013-07-30 |
| 8362048 | Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis | Esther Martinborough, Marcus F. Boehm, Adam Yeager, Junko Tamiya, Liming Huang +6 more | 2013-01-29 |
| 8354513 | Polynucleotides encoding BSL2vcvc-lg | Glen Eugene Mikesell, Han Chang | 2013-01-15 |
| 8227420 | Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID | Robert E. Cohen, Suzette Carr, David Hagerty, Jean-Claude Becker | 2012-07-24 |
| 8148332 | Method for treating a rheumatic disease using a soluble TLA4 molecule | Robert E. Cohen, Suzette Carr, David Hagerty, Jean-Claude Becker | 2012-04-03 |